FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robyn Barst

Research Profile

Disorders

Hypertension, Pulmonary

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Anatomy

Pulmonary Arteries

Co-author Network

Publications

TOP 3
Marius M Hoeper; David Lawrence; Nicholas W Morrell; Andrew J Peacock; Deborah A Quinn; Toru Satoh; Gérald Simonneau; Victor F Tapson; Fernando Torres; Robyn J Barst; Robert C Bourge; Jeremy Feldman; Adaani E Frost; Nazzareno Galié; Miguel Angel Gómez-Sánchez; Friedrich Grimminger; Ekkehard Grünig; Paul M Hassoun; Hossein-Ardeschir Ghofrani
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Mehdi Nouraie ; Enrico Novelli; Timothy B Oriss; Erika Berman Rosenzweig; Vandana Sachdev; Dean E Schraufnagel; Zeyu Xiong; Qilu Zeng; Yingze Zhang; Xuejun Zhao; David B Badesch; Robyn J Barst; Oswaldo L Castro; J Simon R Gibbs; Reda E Girgis; Mark T Gladwin; Jonathan C Goldsmith; Victor R Gordeuk; Kathryn L Hassell; Mariana E Hildesheim; Tamir Kanias; Gregory Kato ; Lakshmanan Krishnamurti; Sophie Lanzkron; Janet S Lee; Jane A Little; Roberto Machado; Claudia R Morris
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
Ian Adatia; Robyn J Barst; Sheila G Haworth; Dunbar Ivy; Abraham Karkowsky; Erika Rosenzweig; Kurt R Stenmark; Max Wegner; Christopher Aguilar
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robyn Barst (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marius M Hoeper; David Lawrence; Nicholas W Morrell; Andrew J Peacock; Deborah A Quinn; Toru Satoh; Gérald Simonneau; Victor F Tapson; Fernando Torres; Robyn J Barst; Robert C Bourge; Jeremy Feldman; Adaani E Frost; Nazzareno Galié; Miguel Angel Gómez-Sánchez; Friedrich Grimminger; Ekkehard Grünig; Paul M Hassoun; Hossein-Ardeschir Ghofrani
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Circulation 2013;127(10):1128-38.
2013: Mehdi Nouraie ; Enrico Novelli; Timothy B Oriss; Erika Berman Rosenzweig; Vandana Sachdev; Dean E Schraufnagel; Zeyu Xiong; Qilu Zeng; Yingze Zhang; Xuejun Zhao; David B Badesch; Robyn J Barst; Oswaldo L Castro; J Simon R Gibbs; Reda E Girgis; Mark T Gladwin; Jonathan C Goldsmith; Victor R Gordeuk; Kathryn L Hassell; Mariana E Hildesheim; Tamir Kanias; Gregory Kato ; Lakshmanan Krishnamurti; Sophie Lanzkron; Janet S Lee; Jane A Little; Roberto Machado; Claudia R Morris
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
Haematologica 2013;98(3):464-72.
2013: Ian Adatia; Robyn J Barst; Sheila G Haworth; Dunbar Ivy; Abraham Karkowsky; Erika Rosenzweig; Kurt R Stenmark; Max Wegner; Christopher Aguilar
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.
Pulmonary circulation 2013;3(1):252-66.
2013: Adaani E Frost; Robyn J Barst; C Gregory Elliott; Harrison W Farber; Dave P Miller; Michael D McGoon
Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Chest 2013;143(1):185-95.
2012: Erika B Rosenzweig; Robyn J Barst
Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery.
Progress in cardiovascular diseases 2012;55(2):128-33.
2012: Natalie Kitterman; Sandra Lombardi; Dave P Miller; Abby Poms; Harrison W Farber; Robyn J Barst
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.
Mayo Clinic proceedings. Mayo Clinic 2012;87(9):825-34.
2012: Ronald J Oudiz; Gerald Simonneau; Robyn J Barst; Anthony Beardsworth; Fady T Botros; Bruce H Brundage; Melanie Chan; Nazzareno Galiè; Hossein Ardeschir Ghofrani
Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.
Journal of the American College of Cardiology 2012;60(8):768-74.
2012: Raymond L Benza; Adaani E Frost; David B Badesch; Robyn J Barst; Dave P Miller; Michael D McGoon
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Chest 2012;142(2):448-56.
2012: Robyn J Barst; Richard N Channick; Dunbar Ivy; Brahm Goldstein
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.
Pulmonary circulation 2012;2(2):139-47.
2012: Michael J Krowka; David B Badesch; Robyn J Barst; Raed A Dweik; Dave P Miller; Darren B Taichman; Michael D McGoon
Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Chest 2012;141(4):906-15.
2012: Rolf M F Berger; Damien Bonnet; Tilman Humpl; D Dunbar Ivy; Zhi-Cheng Jing; Gary E Raskob; Ingram Schulze-Neick; Maurice Beghetti; Robyn J Barst
Clinical features of paediatric pulmonary hypertension: a registry study.
Lancet 2012;379(9815):537-46.
2012: Shelley Shapiro; Glenna L Traiger; Michelle Turner; Prieya Wason; Michael D McGoon; Robyn J Barst
Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Chest 2012;141(2):363-73.
2012: Robyn J Barst; Guillermo Gaitan; Alberto E Garcia; D Dunbar Ivy; Gary R Layton; Tomas Pulido; Andrzej Rudzinski; B K S Sastry; Marjana Serdarevic-Pehar; Andras Szatmari; David L Wessel
A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
Circulation 2012;125(2):324-34.
2011: Sabahat Bokhari; Andrew J Einstein; Robyn J Barst; Erika Berman Rosenweig; Justin Bokhari; Amresh Raina; P Christian Schulze; Lynne L Johnson
PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.
Circulation. Cardiovascular imaging 2011;4(6):641-7.
2011: Vandana Sachdev; Dean E Schraufnagel; James G Taylor; David B Badesch; Robyn J Barst; Oswaldo L Castro; J Simon R Gibbs; Reda E Girgis; Mark T Gladwin; Jonathan C Goldsmith; Victor Roland Gordeuk; Hwaida Hannoush; Kathryn L Hassell; Gregory Kato ; Lakshmanan Krishnamurti; Sophie Lanzkron; Jane A Little; Roberto Machado; Claudia R Morris; Mehdi Nouraie ; Enrico M Novelli; Erika Berman Rosenzweig
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
Circulation 2011;124(13):1452-60.
2011: Roberto Machado; Claudia R Morris; Onyinye Onyekwere; Erika B Rosenzweig; Vandana Sachdev; Dean E Schraufnagel; Myron A Waclawiw; Rob Woolson; Nancy A Yovetich; David B Badesch; Robyn J Barst; Oswaldo L Castro; J Simon R Gibbs; Reda E Girgis; Mark T Gladwin; Jonathan C Goldsmith; Victor Roland Gordeuk; Kathryn L Hassell; Gregory Kato ; Lakshmanan Krishnamurti; Sophie Lanzkron; Jane A Little
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
Blood 2011;118(4):855-64.
2011: Robyn J Barst; Ronald J Oudiz; Anthony Beardsworth; Bruce H Brundage; Gerald Simonneau; Hossein A Ghofrani; David P Sundin; Nazzareno Galiè
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2011;30(6):632-43.
2011: Robyn J Barst
Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?
Pulmonary circulation 2011;1(2):134-7.
2011: Adaani E Frost; David B Badesch; Robyn J Barst; Raymond L Benza; C Gregory Elliott; Harrison W Farber; Abby Krichman; Theodore Liou; Gary E Raskob; Prieya Wason; Kathleen Feldkircher; Michelle Turner; Michael D McGoon
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Chest 2011;139(1):128-37.
2010: D Dunbar Ivy; Erika Berman Rosenzweig; Jean-Christophe Lemarié; Monika Brand; Daniel Rosenberg; Robyn J Barst
Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.
The American journal of cardiology 2010;106(9):1332-8.
2010: Robyn J Barst
How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
International journal of clinical practice. Supplement 2010;(168):23-32.
2010: Hossein A Ghofrani; Nicholas W Morrell; Marius M Hoeper; Horst Olschewski; Andrew J Peacock; Robyn J Barst; Shelley Shapiro; Heiko Golpon; Mark Toshner; Friedrich Grimminger; Steve Pascoe
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.
American journal of respiratory and critical care medicine 2010;182(9):1171-7.
2010: Robyn J Barst
Children deserve the same rights we do: the need for paediatric pulmonary arterial hypertension clinical drug development.
Heart (British Cardiac Society) 2010;96(17):1337-8.
2010: Raymond L Benza; Dave P Miller; Adaani Frost; Robyn J Barst; Abby M Krichman; Michael D McGoon
Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry.
Transplantation 2010;90(3):298-305.
2010: Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor Roland Gordeuk; Cheryl A Hillery; Gregory Kato ; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Pulmonary hypertension and NO in sickle cell.
Blood 2010;116(5):852-4.
2010: Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore Liou; Michael D McGoon
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Circulation 2010;122(2):164-72.
2010: Robyn J Barst; Gabriella Agnoletti; Alain Fraisse; James Baldassarre; David L Wessel
Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension.
Pediatric cardiology 2010;31(5):598-606.
2010: C Gregory Elliott; Robyn J Barst; Werner Seeger; Mateo Porres-Aguilar; Lynette M Brown; Roham T Zamanian; Lewis J Rubin
Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective.
Chest 2010;137(6 Suppl):85S-94S.
2010: Laura Melnick; Robyn J Barst; Cherise A Rowan; Diane Kerstein; Erika Berman Rosenzweig
Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
The American journal of cardiology 2010;105(10):1485-9.
2010: Nazzareno Galiè; Gérald Simonneau; Robyn J Barst; David Badesch; Lewis Rubin
Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
Current opinion in pulmonary medicine 2010;16 Suppl 1():S11-9.
2010: Robyn J Barst; Kamal K Mubarak; Roberto Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul Steven Swerdlow; Mariana Hildesheim; Mark T Gladwin
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.
British journal of haematology 2010;149(3):426-35.
2010: Mardi Gomberg-Maitland; Michael L Maitland; Robyn J Barst; L Sugeng; S Coslet; T J Perrino; L Bond; Mario Lacouture; S L Archer; Mark J Ratain
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
Clinical pharmacology and therapeutics 2010;87(3):303-10.
2010: Laura Rodriguez-Murillo; Ryan Subaran; William C L Stewart; Sreemanta Pramanik; Sudhir Marathe; Robyn J Barst; Wendy Chung; David A Greenberg
Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010;29(2):174-80.
2010: David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
Chest 2010;137(2):376-87.
2009: Maurice Beghetti; Sheila G Haworth; Damien Bonnet; Robyn J Barst; Philippe Acar; Alain Fraisse; Dunbar D Ivy; Xavier Jais; Ingram Schulze-Neick; Nazzareno Galiè; Adele Morganti; Jasper Dingemanse; Andjela Kusic-Pajic; Rolf M F Berger
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.
British journal of clinical pharmacology 2009;68(6):948-55.
2009: David B Badesch; Michael D McGoon; Robyn J Barst; Victor F Tapson; Lewis J Rubin; Fredrick M Wigley; Kenneth M Kral; Ibrahim H Raphiou; Glenn D Crater
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.
The Journal of rheumatology 2009;36(10):2244-9.
2009: Margaret T Lee; Tania Small; Muhammad A Khan; Erika B Rosenzweig; Robyn J Barst; Gary Brittenham
Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.
British journal of haematology 2009;146(4):437-41.
2009: Robyn J Barst; J Simon R Gibbs; Hossein A Ghofrani; Marius M Hoeper; Vallerie V McLaughlin; Lewis J Rubin; Olivier Sitbon; Victor F Tapson; Nazzareno Galiè
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
Journal of the American College of Cardiology 2009;54(1 Suppl):S78-84.
2009: Hossein A Ghofrani; Robyn J Barst; Raymond L Benza; Hunter C Champion; Karen A Fagan; Friedrich Grimminger; Marc Humbert; Gérald Simonneau; Duncan J Stewart; Carlo Ventura; Lewis J Rubin
Future perspectives for the treatment of pulmonary arterial hypertension.
Journal of the American College of Cardiology 2009;54(1 Suppl):S108-17.
2009: Nazzareno Galiè; Bruce H Brundage; Hossein A Ghofrani; Ronald J Oudiz; Gerald Simonneau; Zeenat Safdar; Shelley Shapiro; R James White; Melanie Chan; Anthony Beardsworth; Lyn Frumkin; Robyn J Barst
Tadalafil therapy for pulmonary arterial hypertension.
Circulation 2009;119(22):2894-903.
2009: Robyn J Barst; Duncan Stewart
Conventional and targeted medical therapies.
Cardiology in the young 2009;19 Suppl 1():28-34.
2009: Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
Journal of the American College of Cardiology 2009;53(17):1573-619.
2009: Wendy Chung; Liyong Deng; J Sheila Carroll; Nicole Mallory; Beverly Diamond; Erika Berman Rosenzweig; Robyn J Barst; Jane H Morse
Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2009;28(4):373-9.
2009: Steven M Kawut; Nadine Al-Naamani; Cara Agerstrand; Erika Berman Rosenzweig; Cherise Rowan; Robyn J Barst; Steven Bergmann; Evelyn M Horn
Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.
Chest 2009;135(3):752-9.
2009: Erika Berman Rosenzweig; Robyn J Barst
Pulmonary arterial hypertension in children: a medical update.
Indian journal of pediatrics 2009;76(1):77-81.
2008: Gérald Simonneau; Lewis J Rubin; Nazzareno Galiè; Robyn J Barst; Thomas R Fleming; Adaani E Frost; Peter J Engel; mordechai kramer; gary burgess; Lorraine Collings; Nandini Cossons; Olivier Sitbon; David B Badesch
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Annals of internal medicine 2008;149(8):521-30.
2008: Raymond L Benza; Robyn J Barst; Nazzareno Galie; Adaani Frost; Reda E Girgis; Kristin B Highland; Charlton B. Strange; Carol M Black; David B Badesch; Lewis J Rubin; Thomas R Fleming; Robert Naeije
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
Chest 2008;134(4):775-82.
2008: Michael D McGoon; Abby Krichman; Harrison W Farber; Robyn J Barst; Gary E Raskob; Theodore Liou; Dave P Miller; Kathy Feldkircher; Scott Giles
Design of the REVEAL registry for US patients with pulmonary arterial hypertension.
Mayo Clinic proceedings. Mayo Clinic 2008;83(8):923-31.
2008: Robert P Frantz; Raymond L Benza; Barbro Kjellström; Robert Bourge; Robyn J Barst; Tom D Bennett; Michael D McGoon
Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(7):780-8.
2008: Erika Berman Rosenzweig; Jane H Morse; James A Knowles; Kiran K Chada; Amar M Khan; Kari E Roberts; Jude J McElroy; Nicole K Juskiw; Nicole C Mallory; Stuart Rich; Beverly Diamond; Robyn J Barst
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(6):668-74.
2008: Erika Berman Rosenzweig; Robyn J Barst
Pulmonary arterial hypertension in children: a medical update.
Current opinion in pediatrics 2008;20(3):288-93.
2008: Alexander J Kallen; Edith Lederman; Alexandra Balaji; Ingrid Trevino; Emily E Petersen; Rivka Shoulson; Lisa Saiman; Evelyn M Horn; Mardi Gomberg-Maitland; Robyn J Barst; Arjun Srinivasan
Bloodstream infections in patients given treatment with intravenous prostanoids.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2008;29(4):342-9.
2008: D Dunbar Ivy; Aimee K Doran; Kelly J Smith; George B Mallory; Maurice Beghetti; Robyn J Barst; Daniela Brady; Yuk Law; Donna Parker; Lori Claussen; Steven H Abman
Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.
Journal of the American College of Cardiology 2008;51(2):161-9.
2008: Robyn J Barst
Pulmonary hypertension: past, present and future.
Annals of thoracic medicine 2008;3(1):1-4.
2008: David J Lederer; Evelyn M Horn; Erika Berman Rosenzweig; Wahida Karmally; Megan Jahnes; Robyn J Barst; Steven M Kawut
Plasma serotonin levels are normal in pulmonary arterial hypertension.
Pulmonary pharmacology & therapeutics 2008;21(1):112-4.
2007: David B Badesch; Nicholas S Hill; gary burgess; Lewis J Rubin; Robyn J Barst; Nazzareno Galiè; Gerald Simonneau
Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
The Journal of rheumatology 2007;34(12):2417-22.
2007: Reda E Girgis; Adaani E Frost; Nicholas S Hill; Evelyn M Horn; David Langleben; Vallerie V McLaughlin; Ronald J Oudiz; Ivan M Robbins; James R Seibold; Shelley Shapiro; Victor F Tapson; Robyn J Barst
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
Annals of the rheumatic diseases 2007;66(11):1467-72.
2007: Michael L O'Byrne; Erika S Berman Rosenzweig; Robyn J Barst
The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertension.
Cardiology in the young 2007;17(5):557-9.
2007: Mardi Gomberg-Maitland; Dezheng Huo; Raymond L Benza; Vallerie V McLaughlin; Victor F Tapson; Robyn J Barst
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(7):732-8.
2007: mustafa karamanoglu; Michael D McGoon; Robert P Frantz; Raymond L Benza; Robert Bourge; Robyn J Barst; Barbro Kjellström; Tom D Bennett
Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension.
Chest 2007;132(1):37-43.
2007: Robyn J Barst
Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension?
Journal of the American College of Cardiology 2007;49(14):1572-4.
2007: Robyn J Barst
A review of pulmonary arterial hypertension: role of ambrisentan.
Vascular health and risk management 2007;3(1):11-22.
2007: Raymond L Benza; Sanjay Mehta; Anne Keogh; E Clinton Lawrence; Ronald J Oudiz; Robyn J Barst
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(1):63-9.
2007: Robyn J Barst
Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.
Expert opinion on pharmacotherapy 2007;8(1):95-109.
2006: Marius M Hoeper; Stephen H Lee; Robert Voswinckel; Massimiliano Palazzini; Xavier Jais; Alessandro Marinelli; Robyn J Barst; Hossein A Ghofrani; Zhi-Cheng Jing; Christian F Opitz; Hans-Juergen Seyfarth; Michael Halank; Vallerie V McLaughlin; Ronald J Oudiz; Ralf Ewert; Heinrike Wilkens; Stefan Kluge; Hinrich C Bremer; Eva Baroke; Lewis J Rubin
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers.
Journal of the American College of Cardiology 2006;48(12):2546-52.
2006: Vallerie V McLaughlin; Ronald J Oudiz; Adaani Frost; Victor F Tapson; Srinivas Murali; Richard N Channick; David B Badesch; Robyn J Barst; Henry H Hsu; Lewis J Rubin
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2006;174(11):1257-63.
2006: Robyn J Barst; Nazzareno Galie; Robert Naeije; Gérald Simonneau; Roger Jeffs; Carl Arneson; Lewis J Rubin
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil.
The European respiratory journal 2006;28(6):1195-203.
2006: Norbert F Voelkel; Robert A Quaife; Leslie A Leinwand; Robyn J Barst; Michael D McGoon; Daniel R Meldrum; Jocelyn Dupuis; Carlin S Long; Lewis J Rubin; Frank W Smart; Yuichiro J Suzuki; Mark Gladwin; Elizabeth M Denholm; Dorothy B Gail
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.
Circulation 2006;114(17):1883-91.
2006: Alexander Walker; David Langleben; James J Korelitz; Stuart Rich; Lewis J Rubin; Brian L Strom; René Gonin; Susan Keast; David B Badesch; Robyn J Barst; Robert Bourge; Richard N Channick; Adaani Frost; Sean Gaine; Michael D McGoon; Vallerie V McLaughlin; Srinivas Murali; Ronald J Oudiz; Ivan M Robbins; Victor F Tapson; Lucien Abenhaim; Ginger Constantine
Temporal trends and drug exposures in pulmonary hypertension: an American experience.
American heart journal 2006;152(3):521-6.
2006: Victor F Tapson; Vallerie V McLaughlin; Mardi Gomberg-Maitland; Allison C Widlitz; Abigail Krichman; K J Laliberte; D S Zaccardelli; Robyn J Barst
Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.
The journal of vascular access 2006;7(3):112-7.
2006: Robyn J Barst; David Langleben; David B Badesch; Adaani Frost; E Clinton Lawrence; Shelley Shapiro; Robert Naeije; Nazzareno Galie
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Journal of the American College of Cardiology 2006;47(10):2049-56.
2006: Elisabeth D Willers; John H Newman; James E Loyd; Ivan M Robbins; Lisa A Wheeler; Melissa A Prince; Krista C Stanton; Joy A Cogan; James R Runo; Daniel Byrne; Marc Humbert; Gérald Simonneau; Benjamin Sztrymf; Jane A Morse; James A Knowles; Kari E Roberts; Jude J McElroy; Robyn J Barst; John A Phillips
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2006;173(7):798-802.
2006: Victor F Tapson; Mardi Gomberg-Maitland; Vallerie V McLaughlin; Raymond L Benza; Allison C Widlitz; Abigail Krichman; Robyn J Barst
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.
Chest 2006;129(3):683-8.
2006: Ivan M Robbins; S M Kawut; Delphine Yung; M P Reilly; W Lloyd; G Cunningham; Joseph Loscalzo; S E Kimmel; Brian W Christman; Robyn J Barst
A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
The European respiratory journal 2006;27(3):578-84.
2006: Roberta G Williams; Gail D Pearson; Robyn J Barst; John S Child; Pedro J del Nido; Welton M Gersony; Karen S Kuehl; Michael J Landzberg; Merle Myerson; Steven R Neish; David J Sahn; Amy Verstappen; Carole A Warnes; Catherine Webb
Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease.
Journal of the American College of Cardiology 2006;47(4):701-7.
2006: Erika Berman Rosenzweig; Robyn J Barst
Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.
Treatments in respiratory medicine 2006;5(2):117-27.
2006: Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; David J Lederer; Allison C Widlitz; Erika Berman Rosenzweig; Robyn J Barst
Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.
Pulmonary pharmacology & therapeutics 2006;19(5):370-4.
2006: Ronald J Oudiz; Robyn J Barst; James E Hansen; Xing-Guo Sun; Robert Garofano; Xionghua Wu; Karlman Wasserman
Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.
The American journal of cardiology 2006;97(1):123-6.
2005: Mardi Gomberg-Maitland; Victor F Tapson; Raymond L Benza; Vallerie V McLaughlin; Abigail Krichman; Allison C Widlitz; Robyn J Barst
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
American journal of respiratory and critical care medicine 2005;172(12):1586-9.
2005: Kari E Roberts; Robyn J Barst; Jude J McElroy; Allison C Widlitz; Kiran Chada; James A Knowles; Jane H Morse
Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.
Chest 2005;128(6 Suppl):618S.
2005: Olivier Sitbon; Vallerie V McLaughlin; David B Badesch; Robyn J Barst; C Black; Nazzareno Galiè; Marc Humbert; Maurizio Rainisio; Lewis J Rubin; Gérald Simonneau
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
Thorax 2005;60(12):1025-30.
2005: Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David B Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Sildenafil citrate therapy for pulmonary arterial hypertension.
The New England journal of medicine 2005;353(20):2148-57.
2005: Allison C Widlitz; Robyn J Barst; Evelyn M Horn
Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.
Expert review of cardiovascular therapy 2005;3(6):985-91.
2005: Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Allison C Widlitz; Erika Berman Rosenzweig; Robyn J Barst
von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.
Chest 2005;128(4):2355-62.
2005: Robyn J Barst
PDGF signaling in pulmonary arterial hypertension.
The Journal of clinical investigation 2005;115(10):2691-4.
2005: Erika Berman Rosenzweig; D Dunbar Ivy; Allison C Widlitz; Aimee Doran; Lori Claussen; Delphine Yung; Steven H Abman; Adele Morganti; Ngoc Nguyen; Robyn J Barst
Effects of long-term bosentan in children with pulmonary arterial hypertension.
Journal of the American College of Cardiology 2005;46(4):697-704.
2005: Roberto Machado; Sabrina Martyr; Gregory Kato ; Robyn J Barst; Anastasia Anthi; Michael R Robinson; Lori Hunter; Wynona A Coles; James Nichols; Christian Hunter; Vandana Sachdev; Oswaldo Castro; Mark T Gladwin
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.
British journal of haematology 2005;130(3):445-53.
2005: Erika Berman Rosenzweig; Robyn J Barst
Idiopathic pulmonary arterial hypertension in children.
Current opinion in pediatrics 2005;17(3):372-80.
2005: Adaani E Frost; David Langleben; Ronald J Oudiz; Nicholas Hill; E Horn; Vallerie V McLaughlin; Ivan M Robbins; Shelley Shapiro; Victor F Tapson; Diane Zwicke; T DeMarco; Robert J Schilz; Melvyn Rubenfire; Robyn J Barst
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
Vascular pharmacology 2005;43(1):36-9.
2005: Nazzareno Galiè; Adam Torbicki; Robyn J Barst; Philippe Dartevelle; Sheila Haworth; Tim Higenbottam; Horst Olschewski; Andrew Peacock; Giuseppe Pietra; Lewis J Rubin; Gérald Simonneau
[Guidelines on diagnosis and treatment of pulmonary arterial hypertension].
Revista española de cardiología 2005;58(5):523-66.
2005: Vallerie V McLaughlin; Olivier Sitbon; David B Badesch; Robyn J Barst; C Black; Nazzareno Galiè; Maurizio Rainisio; Gérald Simonneau; Lewis J Rubin
Survival with first-line bosentan in patients with primary pulmonary hypertension.
The European respiratory journal 2005;25(2):244-9.
2005: Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Robert Garofano; Rochelle L Goldsmith; Allison C Widlitz; Erika Berman Rosenzweig; Diane Kerstein; Robyn J Barst
New predictors of outcome in idiopathic pulmonary arterial hypertension.
The American journal of cardiology 2005;95(2):199-203.
2004: Evelyn M Horn; Allison C Widlitz; Robyn J Barst
Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.
Expert opinion on investigational drugs 2004;13(11):1483-92.
2004: David Langleben; Andrew M Hirsch; Eileen Shalit; Lyda Lesenko; Robyn J Barst
Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study.
Chest 2004;126(4):1377-81.
2004: James E Hansen; Xing-Guo Sun; Yuji Yasunobu; Robert P Garafano; Gregory Gates; Robyn J Barst; Karlman Wasserman
Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension.
Chest 2004;126(3):816-24.
2004: Kari E Roberts; Jude J McElroy; W P K Wong; E Yen; Allison C Widlitz; Robyn J Barst; James A Knowles; Jane H Morse
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.
The European respiratory journal 2004;24(3):371-4.
2004: M Humbert; Robyn J Barst; Ivan M Robbins; Richard N Channick; Nazzareno Galiè; A Boonstra; Lewis J Rubin; Evelyn M Horn; Alessandra Manes; Gérald Simonneau
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
The European respiratory journal 2004;24(3):353-9.
2004: Delphine Yung; Allison C Widlitz; Erika Berman Rosenzweig; Diane Kerstein; Greg Maislin; Robyn J Barst
Outcomes in children with idiopathic pulmonary arterial hypertension.
Circulation 2004;110(6):660-5.
2004: Ronald J Oudiz; Robert J Schilz; Robyn J Barst; Nazzareno Galié; Stuart Rich; Lewis J Rubin; Gérald Simonneau
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
Chest 2004;126(2):420-7.
2004: David B Badesch; Steve H Abman; Gregory S Ahearn; Robyn J Barst; Douglas C McCrory; Gerald Simonneau; Vallerie V McLaughlin
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
Chest 2004;126(1 Suppl):35S-62S.
2004: Ronald J Oudiz; Allison C Widlitz; X Joy Beckmann; Daisy Camanga; Jose Alfie; Bruce H Brundage; Robyn J Barst
Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.
Chest 2004;126(1):90-4.
2004: Erika Berman Rosenzweig; Allison C Widlitz; Robyn J Barst
Pulmonary arterial hypertension in children.
Pediatric pulmonology 2004;38(1):2-22.
2004: John H Newman; Barry L Fanburg; Stephen L Archer; David B Badesch; Robyn J Barst; Joe G. N. Garcia; Peter N Kao; James A Knowles; James E Loyd; Michael D McGoon; Jane H Morse; William C Nichols; Marlene Rabinovitch; David M Rodman; Troy Stevens; Rubin M Tuder; Norbert F Voelkel; Dorothy B Gail
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
Circulation 2004;109(24):2947-52.
2004: Richard N Channick; Olivier Sitbon; Robyn J Barst; Alessandra Manes; Lewis J Rubin
Endothelin receptor antagonists in pulmonary arterial hypertension.
Journal of the American College of Cardiology 2004;43(12 Suppl S):62S-67S.
2004: David B Badesch; Vallerie V McLaughlin; Marion Delcroix; Carmine Dario Vizza; Horst Olschewski; Olivier Sitbon; Robyn J Barst
Prostanoid therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 2004;43(12 Suppl S):56S-61S.
2004: Robyn J Barst; Michael D McGoon; Adam Torbicki; Olivier Sitbon; Michael J Krowka; Horst Olschewski; Sean Gaine
Diagnosis and differential assessment of pulmonary arterial hypertension.
Journal of the American College of Cardiology 2004;43(12 Suppl S):40S-47S.
2004: Ellis W Lader; Christopher P Cannon; Erik Ohman; L Kristin Newby; Daniel P Sulmasy; Robyn J Barst; Joan M Fair; Marcus Flather; Jane E Freedman; Robert L Frye; Mary M Hand; Robert L Jesse; Frans Van de Werf; Fernando Costa
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
Circulation 2004;109(21):e305-7.
2004: Ellis W Lader; Christopher P Cannon; Erik Ohman; L Kristin Newby; Daniel P Sulmasy; Robyn J Barst; Joan M Fair; Marcus Flather; Jane E Freedman; Robert L Frye; Mary M Hand; Robert L Jesse; Frans Van de Werf; Fernando Costa
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
Circulation 2004;109(21):e302-4.
2004: Ellis W Lader; Christopher P Cannon; Erik Ohman; L Kristin Newby; Daniel P Sulmasy; Robyn J Barst; Joan M Fair; Marcus Flather; Jane E Freedman; Robert L Frye; Mary M Hand; Robert L Jesse; Frans Van de Werf; Fernando Costa
The clinician as investigator: participating in clinical trials in the practice setting.
Circulation 2004;109(21):2672-9.
2004: Robyn J Barst
Evaluation and treatment for angina in pulmonary arterial hypertension.
The American journal of medicine 2004;116(6):427-8.
2004: Salma A Abdalla; Carol J Gallione; Robyn J Barst; Evelyn M Horn; James A Knowles; Douglas A Marchuk; Michelle Letarte; Jane H Morse
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.
The European respiratory journal 2004;23(3):373-7.
2004: Erika Berman Rosenzweig; Kelly A Schmitt; Robert Garofano; Robyn J Barst
Identical twins with primary pulmonary hypertension: beraprost vs epoprostenol.
Chest 2004;125(3):1157-60.
2004: Robyn J Barst; David Langleben; Adaani Frost; Evelyn M Horn; Ronald J Oudiz; Shelley Shapiro; Vallerie V McLaughlin; Nicholas Hill; Victor F Tapson; Ivan M Robbins; Diane Zwicke; Benjamin Duncan; Richard A F Dixon; Lyn R Frumkin
Sitaxsentan therapy for pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2004;169(4):441-7.
2004: Deepa Rastogi; Pakkay Ngai; Robyn J Barst; Anastassios Koumbourlis
Lower airway obstruction, bronchial hyperresponsiveness, and primary pulmonary hypertension in children.
Pediatric pulmonology 2004;37(1):50-5.
2003: Robyn J Barst; Michael D McGoon; Vallerie V McLaughlin; Victor F Tapson; Stuart Rich; Lewis J Rubin; Karlman Wasserman; Ronald J Oudiz; Shelley Shapiro; Ivan M Robbins; Richard N Channick; David B Badesch; Barry K Rayburn; Robin Flinchbaugh; Jeff Sigman; Carl Arneson; Roger Jeffs
Beraprost therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 2003;41(12):2119-25.
2003: Hilario Nunes; Marc Humbert; Olivier Sitbon; Jane H Morse; Zemin Deng; James A Knowles; Catherine Le Gall; Florence Parent; Gilles Garcia; Philippe Hervé; Robyn J Barst; Gérald Simonneau
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2003;167(10):1433-9.
2003: Nazzareno Galiè; Alan L Hinderliter; Adam Torbicki; Thierry Fourme; Gérald Simonneau; Tomas Pulido; Nilda Espinola-Zavaleta; Guido Rocchi; Alessandra Manes; Robert Frantz; Marcin Kurzyna; Sherif F Nagueh; Robyn J Barst; Richard N Channick; Karl Dujardin; Andrew Kronenberg; Isabelle Leconte; Maurizio Rainisio; Lewis J Rubin
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
Journal of the American College of Cardiology 2003;41(8):1380-6.
2003: Robyn J Barst; D Dunbar Ivy; Jasper Dingemanse; Allison C Widlitz; Kelly Schmitt; Aimee Doran; Deborah Bingaman; Ngoc Nguyen; Michael Gaitonde; Paul L M van Giersbergen
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.
Clinical pharmacology and therapeutics 2003;73(4):372-82.
2003: Vallerie V McLaughlin; Sean Gaine; Robyn J Barst; Ronald J Oudiz; Robert Bourge; Adaani Frost; Ivan M Robbins; Victor F Tapson; Michael D McGoon; David B Badesch; Jeff Sigman; Robert Roscigno; Shelmer D Blackburn; Carl Arneson; Lewis J Rubin; Stuart Rich
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
Journal of cardiovascular pharmacology 2003;41(2):293-9.
2003: Allison C Widlitz; Robyn J Barst
Pulmonary arterial hypertension in children.
The European respiratory journal 2003;21(1):155-76.
2002: Evelyn M Horn; Robyn J Barst
Treprostinil therapy for pulmonary artery hypertension.
Expert opinion on investigational drugs 2002;11(11):1615-22.
2002: Jane Morse; Robyn J Barst; Evelyn Horn; Nieves Cuervo; Zemin Deng; James Knowles
Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.
The Journal of rheumatology 2002;29(11):2379-81.
2002: Erika Berman Berman; Robyn J Barst
Eisenmenger's syndrome: current management.
Progress in cardiovascular diseases 2002;45(2):129-38.
2002: M Humbert; Zemin Deng; Gérald Simonneau; Robyn J Barst; Olivier Sitbon; M Wolf; Nieves Cuervo; K J Moore; Susan E Hodge; James A Knowles; Jane H Morse
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
The European respiratory journal 2002;20(3):518-23.
2002: Robyn J Barst; Stuart Rich; Allison C Widlitz; Evelyn M Horn; Vallerie V McLaughlin; Joyce McFarlin
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.
Chest 2002;121(6):1860-8.
2002: Catherine Webb; Kathy J Jenkins; Peter P Karpawich; Ann F Bolger; Richard M Donner; Hugh D Allen; Robyn J Barst
Collaborative care for adults with congenital heart disease.
Circulation 2002;105(19):2318-23.
2002: David Langleben; Brian W Christman; Robyn J Barst; Virgil C Dias; Nazzareno Galiè; Timothy W Higenbottam; Meinhard Kneussl; Larry Korducki; Robert Naeije; Axel Riedel; Gérald Simonneau; Andrew M Hirsch; Stuart Rich; Ivan M Robbins; Ronald J Oudiz; Michael D McGoon; David B Badesch; Robert D Levy; Sanjay Mehta; Werner Seeger; Markus Solèr
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
American heart journal 2002;143(5):E4.
2002: Jean-Luc Vachiéry; Nicholas Hill; Diane Zwicke; Robyn J Barst; Shelmer Blackburn; Robert Naeije
Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension.
Chest 2002;121(5):1561-5.
2002: Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael J Landzberg; Gérald Simonneau
Bosentan therapy for pulmonary arterial hypertension.
The New England journal of medicine 2002;346(12):896-903.
2002: Gérald Simonneau; Robyn J Barst; Nazzareno Galie; Robert Naeije; Stuart Rich; Robert Bourge; Anne Keogh; Ronald J Oudiz; Adaani Frost; Shelmer D Blackburn; James W Crow; Lewis J Rubin
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
American journal of respiratory and critical care medicine 2002;165(6):800-4.
2002: Kenneth Nichols; Rola Saouaf; Ala'eldin A Ababneh; Robyn J Barst; Marlon S Rosenbaum; Mark W Groch; Abu Shoyeb; Steven Bergmann
Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2002;9(2):153-60.
2002: Marius M Hoeper; Nazzareno Galié; Srinivas Murali; Horst Olschewski; Melvyn Rubenfire; Ivan M Robbins; Harrison W Farber; Vallerie V McLaughlin; Shelley Shapiro; Joanna Pepke-Zaba; Joerg Winkler; Ralf Ewert; Christian F Opitz; Volker Westerkamp; Jean-Luc Vachiéry; Adam Torbicki; Jürgen Behr; Robyn J Barst
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 2002;165(3):341-4.
2001: Ivan M Robbins; Robyn J Barst; Lewis J Rubin; Sean Gaine; P V Price; Jason D Morrow; Brian W Christman
Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.
Chest 2001;120(5):1639-44.
2001: Robyn J Barst
Medical therapy of pulmonary hypertension. An overview of treatment and goals.
Clinics in chest medicine 2001;22(3):509-15, ix.
2001: A Ferris; T Jacobs; Allison C Widlitz; Robyn J Barst; Jane H Morse
Pulmonary arterial hypertension and thyroid disease.
Chest 2001;119(6):1980-1.
2001: Erika Berman Rosenzweig; Robyn J Barst
Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension.
Expert opinion on investigational drugs 2001;10(5):811-23.
2000: Zemin Deng; Jane H Morse; Susan L Slager; Nieves Cuervo; K J Moore; G Venetos; Sergey Kalachikov; Eftihia Cayanis; SG Fischer; Robyn J Barst; Susan E Hodge; James A Knowles
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.
American journal of human genetics 2000;67(3):737-44.
2000: David B Badesch; Victor F Tapson; Michael D McGoon; B H Brundage; Lewis J Rubin; Fredrick M Wigley; Stuart Rich; Robyn J Barst; P S Barrett; K M Kral; Maria M Jöbsis; James E Loyd; S Murali; Adaani Frost; Reda E Girgis; Robert Bourge; D D Ralph; C Gregory Elliott; Nicholas S Hill; David Langleben; Robert J Schilz; Vallerie V McLaughlin; Ivan M Robbins; Bertron M Groves; Shelley Shapiro; T A Medsger
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Annals of internal medicine 2000;132(6):425-34.
2000: Zemin Deng; faride haghighi; L Helleby; K Vanterpool; Evelyn M Horn; Robyn J Barst; Susan E Hodge; Jane H Morse; James A Knowles
Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33.
American journal of respiratory and critical care medicine 2000;161(3 Pt 1):1055-9.
1999: D Wax; Robert Garofano; Robyn J Barst
Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Chest 1999;116(4):914-20.
1999: Jane H Morse; Evelyn M Horn; Robyn J Barst
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension.
Chest 1999;116(3):847.
1999: David Langleben; Robyn J Barst; David B Badesch; Bertron M Groves; Victor F Tapson; S Murali; Robert Bourge; Neil A Ettinger; E Shalit; Linda M Clayton; Maria M Jöbsis; Shelmer D Blackburn; James W Crow; D J Stewart; Walker Long
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.
Circulation 1999;99(25):3266-71.
1999: Erika Berman Rosenzweig; Diane Kerstein; Robyn J Barst
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
Circulation 1999;99(14):1858-65.
1999: Robyn J Barst
Recent advances in the treatment of pediatric pulmonary artery hypertension.
Pediatric clinics of North America 1999;46(2):331-45.
1999: Robyn J Barst; Greg Maislin; A P Fishman
Vasodilator therapy for primary pulmonary hypertension in children.
Circulation 1999;99(9):1197-208.
1999: Robert Garofano; Robyn J Barst
Exercise testing in children with primary pulmonary hypertension.
Pediatric cardiology 1999;20(1):61-4; discussion 65.
1998: Robyn J Barst; J E Loyd
Genetics and immunogenetic aspects of primary pulmonary hypertension.
Chest 1998;114(3 Suppl):231S-236S.
1998: Jane H Morse; AC Jones; Robyn J Barst; Susan E Hodge; Kirk Wilhelmsen; TG Nygaard
Familial primary pulmonary hypertension locus mapped to chromosome 2q31-q32.
Chest 1998;114(1 Suppl):57S-58S.
1997: R Friedman; J Gregory Mears; Robyn J Barst
Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
Circulation 1997;96(9):2782-4.
1997: Jane H Morse; Robyn J Barst
Detection of familial primary pulmonary hypertension by genetic testing.
The New England journal of medicine 1997;337(3):202-3.
1997: Jane H Morse; AC Jones; Robyn J Barst; Susan E Hodge; Kirk Wilhelmsen; TG Nygaard
Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32.
Circulation 1997;95(12):2603-6.
1997: Alan L Hinderliter; Park W Willis; Robyn J Barst; Stuart Rich; Lewis J Rubin; David B Badesch; Bertron M Groves; Michael D McGoon; Victor F Tapson; Robert Bourge; B H Brundage; S K Koerner; David Langleben; C A Keller; S Murali; B F Uretsky; Gary G Koch; Shu Li; Linda M Clayton; Maria M Jöbsis; Shelmer D Blackburn; James W Crow; W A Long
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.
Circulation 1997;95(6):1479-86.
1997: Jane H Morse; Robyn J Barst; M Fotino; Y Zhang; Edith Flaster; A E Gharavi; M J Fritzler; M Dominguez; E Angles-Cano
Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7.
American journal of respiratory and critical care medicine 1997;155(1):274-8.
1996: Jane H Morse; Robyn J Barst; M Fotino; Y Zhang; E Flaster; M J Fritzler
Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone.
Clinical and experimental immunology 1996;106(2):389-95.
1996: Howard Apfel; Z Shen; A S Gopal; V Vangi; D Solowiejczyk; K Altmann; Robyn J Barst; Lawrence M Boxt; Lindsey D Allan; Donald L King
Quantitative three dimensional echocardiography in patients with pulmonary hypertension and compressed left ventricles: comparison with cross sectional echocardiography and magnetic resonance imaging.
Heart (British Cardiac Society) 1996;76(4):350-4.
1996: Howard Apfel; D E Solowiejczyk; B F Printz; M Challenger; D K Blood; Lawrence M Boxt; Robyn J Barst; Welton M Gersony
Feasibility of a two-dimensional echocardiographic method for the clinical assessment of right ventricular volume and function in children.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 1996;9(5):637-45.
1996: Jane H Morse; Robyn J Barst; Silviu Itescu; E R Flaster; GITA SINHA; Y Zhang; M Fotino
Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles.
American journal of respiratory and critical care medicine 1996;153(4 Pt 1):1299-301.
1996: Robyn J Barst; Lewis J Rubin; W A Long; M D McGoon; S Rich; David B Badesch; Bertron M Groves; Victor F Tapson; Robert Bourge; B H Brundage; S D Blackburn; L M Clayton; J W Crow; M M Jöbsis; C A Keller; S K Koerner; D Langleben; S Murali; D Shortino; B F Uretsky
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
The New England journal of medicine 1996;334(5):296-301.
1995: D Kerstein; P S Levy; Daphne Hsu; A J Hordof; Welton M Gersony; Robyn J Barst
Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension.
Circulation 1995;91(7):2028-35.
1995: D E Solowiejczyk; M M Cooper; Robyn J Barst; J M Quaegebeur; Welton M Gersony
Pulmonary atresia and ventricular septal defect with coronary artery to pulmonary artery fistula: case report and review of the literature.
Pediatric cardiology 1995;16(2):90-4.
1994: Robyn J Barst; Lewis J Rubin; M D McGoon; E J Caldwell; W A Long; P S Levy
Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
Annals of internal medicine 1994;121(6):409-15.
1994: T I Murray; Lawrence M Boxt; J Katz; K Reagan; Robyn J Barst
Estimation of pulmonary artery pressure in patients with primary pulmonary hypertension by quantitative analysis of magnetic resonance images.
Journal of thoracic imaging 1994;9(3):198-204.
1993: J Katz; J Whang; Lawrence M Boxt; Robyn J Barst
Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.
Journal of the American College of Cardiology 1993;21(6):1475-81.
1992: Lawrence M Boxt; J Katz; T Kolb; F P Czegledy; Robyn J Barst
Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension.
Journal of the American College of Cardiology 1992;19(7):1508-15.
1992: Jane H Morse; Robyn J Barst; M Fotino
Familial pulmonary hypertension: immunogenetic findings in four Caucasian kindreds.
The American review of respiratory disease 1992;145(4 Pt 1):787-92.
1992: Robyn J Barst; E R Flaster; A Menon; M Fotino; Jane H Morse
Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex.
Circulation 1992;85(1):249-58.
1991: G E D'Alonzo; Robyn J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
Annals of internal medicine 1991;115(5):343-9.
1990: Lewis J Rubin; J Mendoza; M Hood; M McGoon; Robyn J Barst; W B Williams; J H Diehl; J Crow; W Long
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Annals of internal medicine 1990;112(7):485-91.
1989: Jane H Morse; Robyn J Barst; H H Whitman; M Fotino; Jerry C Jacobs
Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"?
The Journal of rheumatology 1989;16(12):1536-41.
1989: Robyn J Barst; Welton M Gersony
The pharmacological treatment of patent ductus arteriosus. A review of the evidence.
Drugs 1989;38(2):249-66.
1986: D M Friedman; Fredrick Bierman; Robyn J Barst
Gated pulsed Doppler evaluation of idiopathic pulmonary artery hypertension in children.
The American journal of cardiology 1986;58(3):369-70.
1985: C N Steeg; Fredrick Bierman; A J Hordof; C J Hayes; E Krongrad; Robyn J Barst
"Bedside" balloon septostomy in infants with transposition of the great arteries: new concepts using two-dimensional echocardiographic techniques.
The Journal of pediatrics 1985;107(6):944-6.
1985: Robyn J Barst; S A Stalcup
Endothelial function in clinical pulmonary hypertension.
Chest 1985;88(4 Suppl):216S-220S.
1985: Robyn J Barst; S A Stalcup; C N Steeg; J C Hall; M F Frosolono; A E Cato; R B Mellins
Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child.
The American review of respiratory disease 1985;131(1):171-7.
1983: S A Stalcup; Robyn J Barst; R B Mellins
Endothelial cell function in hypoxic environments: contributions to circulatory adjustments to high altitude.
Progress in clinical and biological research 1983;136():111-24.